Advancements in technology in patient registry software is expected to boost growth 2026: Global Vision Technologies, Inc., Quintiles Inc., Dacima Software Inc., PatientCrossroads, Evado eClinical Solutions, Mckesson Corporation

Major market players are focusing on introduction of innovative products for improving hospital patient registry work flow and clinical outcomes. This is expected to boost growth of the market. For instance, in March 2018, Rush University Medical Center in Chicago launched a cloud-based surgical oncology research team (SORT) registry. SORT is designed to function across multicenter platforms to gather psychosocial, oncological, and functional outcome data. Its cloud based registry provides a research platform that enables the user’s institution to gather their own data while partnering with other organization. Main characteristic of SORT registry is to collect functional scores using Musculoskeletal Tumor Society (MSTS) functional evaluation tool and patient reported outcomes both at follow up and presentation.

Get a Request Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2055

Healthcare system cost in developed countries is increasing due to increase in healthcare expenditures, high cost involved with the usage of advanced medical technology, and pharmaceutical expenditure, as well as high prevalence of chronic diseases and their financial consequence is urging government and private organizations, all over the globe, to work together for common patient registry solutions. For instance, 2013 Advanced Biological Laboratories (ABL) South Africa signed a contract with Spanish Asociación para el Estudio del Hídago for licensing and development of the new HepatiC software and database system. HepatiC offers hepatitis C (HCV) patient registry and database to aid in the management of HCV-infected patients receiving direct acting antiviral therapy.

Moreover, key players are focusing on collaboration, mergers, and partnership with other companies and institutes to retain dominant position in the market. These factors are expected to propel growth of global patient registry market over the forecast period. For instance, in 2014 Cancer Commons and The Melanoma Research Foundation (MRF) launched 'donate your data (DYD) Program', an online registry for melanoma patients and survivors. Donate your data program encourages patients to anonymously share their cancer experiences for advance research.

For instance, According to North American Association of Central Cancer Registries (NAACCR) 2018, Nine Canadian (8 Provinces and 1 territory) and 55 U.S. registries (49 states, Puerto Rico, and 4 metropolitan and 1 regional registry) were certified by NAACCR. The percentage of the North American population that is covered by high quality certified registries for 2018 is approximately 93%.

The insights in patient’s registry data can be useful for policymakers, for demonstrating that the particular service or item was provided properly to the patients meeting the specific characteristics, and to collect new information, which was not available in the existing clinical trials and research. The creation of disease specific data registries has been recommended for improving patient care. The use of registries to assess performance of health sector or risk-sharing arrangement is increasing in countries such as France, the U.K., Australia, and Germany. This is also expected to further support growth of the market.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/2055

Key players operating in the patient registry software market are Global Vision Technologies, Inc., Quintiles Inc., Dacima Software Inc., PatientCrossroads, Evado eClinical Solutions, Mckesson Corporation, Liaison Technologies, and Imagetrend, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.